Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ratchaphruek Hospital PCLBKK:RPH-R 85 Intrinsic Value: Projected FCF is ฿6.98 as of Jul. 22, 2026, which is 100% below its 10-year median of 1.33. GuruFocus rates BKK:RPH-R with a GF Score™ of 85/100 and a GF Value™ of ฿5.89. The stock has 4 warning signs investors should review. Among 340 Healthcare Providers & Services companies, Ratchaphruek Hospital PCL ranks better than 72.94% on this metric.
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.
The historical rank and industry rank for Ratchaphruek Hospital PCL's Intrinsic Value: Projected FCF or its related term are showing as below:
BKK:RPH-R'
s Price-to-Projected-FCF Range Over the Past 10 Years
Min: 0.64 Med: 1.33 Max: 87.14
Current: 0.7
During the past 13 years, the highest Price-to-Intrinsic-Value-Projected-FCF of Ratchaphruek Hospital PCL was 87.14. The lowest was 0.64. And the median was 1.33.
BKK:RPH-R's Price-to-Projected-FCF is ranked better than 72.94% of 340
companies
in the Healthcare Providers & Services industry
Industry Median: 1.06
vs BKK:RPH-R: 0.70
The growth multiple is capped between 8.35 and 17.74.
Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.
Ratchaphruek Hospital PCL's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as
Price-to-Intrinsic-Value-Projected-FCF
=
Share Price
/
Intrinsic Value: Projected FCF
=
4.88
/
7.1528493573352
=
0.68
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ratchaphruek Hospital PCL Intrinsic Value: Projected FCF Related Terms
Ratchaphruek Hospital PCL Intrinsic Value: Projected FCF Historical Data
* Premium members only.
The historical data trend for Ratchaphruek Hospital PCL's Intrinsic Value: Projected FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:RPH-R vs HCA, THC, DVA: Intrinsic Value: Projected FCF Comparison
For the Medical Care Facilities subindustry, Ratchaphruek Hospital PCL's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ratchaphruek Hospital PCL Price-to-Projected-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ratchaphruek Hospital PCL's Price-to-Projected-FCF distribution charts can be found below:
* The bar in red indicates where Ratchaphruek Hospital PCL's Price-to-Projected-FCF falls into.
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.
The details of how we calculate the intrinsic value of stocks are described in detail here.
This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Intrinsic Value: Projected FCF of ฿6.98 mean?
Ratchaphruek Hospital PCL (BKK:RPH-R) has a Intrinsic Value: Projected FCF of ฿6.98 as of Jul. 22, 2026. Intrinsic Value: Projected FCF is the stock value based on a projected free cash flow model. View historical data on Ratchaphruek Hospital PCL and its competitors. This is 425% above median its historical median of 1.33. Over the past decade, Ratchaphruek Hospital PCL's Intrinsic Value: Projected FCF has ranged from 0.64 to 87.14. According to the industry distribution chart, Ratchaphruek Hospital PCL ranks #92 out of 340 companies in the Healthcare Providers & Services industry, placing it in the top 27.1%.
Is Ratchaphruek Hospital PCL's Intrinsic Value: Projected FCF too high?
Ratchaphruek Hospital PCL's current Intrinsic Value: Projected FCF of ฿6.98 is 425% above median its 10-year median of 1.33. Over the past 10 years, this metric has ranged from a low of 0.64 to a high of 87.14. Based on the distribution chart, Ratchaphruek Hospital PCL ranks #92 out of 340 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Ratchaphruek Hospital PCL has a GF Score™ of 85/100, reflecting its overall financial health beyond just this single metric.
How does Ratchaphruek Hospital PCL's Intrinsic Value: Projected FCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Ratchaphruek Hospital PCL ranks #92 out of 340 companies for Intrinsic Value: Projected FCF. This puts Ratchaphruek Hospital PCL in the upper half of its industry. The industry median Intrinsic Value: Projected FCF is 1.06. Historically, Ratchaphruek Hospital PCL's own Intrinsic Value: Projected FCF has ranged from 0.64 to 87.14 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Intrinsic Value: Projected FCF for a Healthcare Providers & Services company?
The median Intrinsic Value: Projected FCF among Healthcare Providers & Services companies is 1.06, based on 340 companies in the industry. Companies in the top quartile (top 25%) have a Intrinsic Value: Projected FCF significantly above this median, while those in the bottom quartile fall well below. However, Intrinsic Value: Projected FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Intrinsic Value: Projected FCF mean?
A high Intrinsic Value: Projected FCF can signal that a stock is expensive relative to its fundamentals. Intrinsic Value: Projected FCF is the stock value based on a projected free cash flow model. View historical data on Ratchaphruek Hospital PCL and its competitors. For the Healthcare Providers & Services industry, the median Intrinsic Value: Projected FCF is 1.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ratchaphruek Hospital PCL's current Intrinsic Value: Projected FCF is ฿6.98, which is 425% above median its own 10-year median of 1.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ratchaphruek Hospital PCL stock overvalued right now?
Ratchaphruek Hospital PCL (BKK:RPH-R) has a current Intrinsic Value: Projected FCF of ฿6.98. The stock's GF Value™ is ฿5.89, compared to a current price of ฿4.88 — trading 17.1% below its estimated fair value. The current Intrinsic Value: Projected FCF is ฿6.98, which is 425% above median its 10-year median of 1.33. Ratchaphruek Hospital PCL's overall GF Score™ is 85/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Intrinsic Value: Projected FCF calculated?
Intrinsic Value: Projected FCF is calculated from a company's financial statements. For Ratchaphruek Hospital PCL (BKK:RPH-R), the current Intrinsic Value: Projected FCF is ฿6.98 as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ratchaphruek Hospital PCL (BKK:RPH-R) Overvalued in 2026?
Based on GuruFocus' analysis, Ratchaphruek Hospital PCL stock appears to be undervalued.
The current stock price of ฿4.88 is trading 17.1% below its estimated GF Value™ of ฿5.89.
Key valuation signals for BKK:RPH-R:
Intrinsic Value: Projected FCF: ฿6.98 (425% above median its 10-year median of 1.33)
GF Value™: ฿5.89 vs. price of ฿4.88 (17.1% below fair value)
No single metric tells the full story. See the BKK:RPH-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ratchaphruek Hospital PCL is engaged in the hospital business. It provides medical services comprising in-patient department, which derives maximum revenue, and out-patient departments. Some of the services include Surgery, Pediatric, Orthopedic, Obstetrics and Gynecology, and others. The company also operates in a single geographic area, which is Thailand.
85GF Score
Get the complete analysis for BKK:RPH-R
Intrinsic Value: Projected FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:RPH-R has been successfully added to your 
